Erratum: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the prostate cancer clinical trials consortium (Investigational New Drugs DOI: 10.1007/s10637-010-9420-8)

Deborah A. Bradley, Stephanie Daignault, Charles J. Ryan, Robert S. DiPaola, Kathleen A. Cooney, David C. Smith, Eric Small, Paul Mathew, Mitchell E. Gross, Mark N. Stein, Alice Chen, Kenneth J. Pienta, June Escara-Wilke, Gerald Doyle, Mahmoud Al-Hawary, Evan T. Keller, Maha Hussain

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Pages (from-to)1517-1518
    Number of pages2
    JournalInvestigational New Drugs
    Issue number6
    StatePublished - Dec 2011

    All Science Journal Classification (ASJC) codes

    • Oncology
    • Pharmacology
    • Pharmacology (medical)

    Cite this